Skip to content
NHLS WCA Number: 990000306648
Login to:
Thusano Portal
Proficiency Testing
Lab Results
WEB PTS Registration
CDW MicroStrategy
CSA
Staff Email
Contact Us
Search for:
Home
About Us
Overview
Board of Directors
Executive Management
Area Managers
Institutes & Subsidiaries
Laboratories
NHLS Achievements
Terms of Use
COVID-19
Frequently Asked Questions
Returning To Work Frequently Asked Questions
COVID-19 Surveillance Reports
COVID-19 Vaccine
Variant tracking in South Africa
COVID-19 Technical Resources
COVID-19 Guidelines
COVID-19 Advice For The Public
COVID-19 Prevention
COVID-19 Advice For Travellers
Long COVID
COVID-19 Vaccine Breakthrough Cases Frequently Asked Questions
COVID-19 Resources For Children
COVID-19 Communication Resources
COVID-19 Contact Resources
Cholera
Cholera Frequently Asked Questions
Case Management Summary
Specimen Collection Form
Our Services
Diagnostic
Type Of Tests
Diagnostic Media Products
Paternity Testing
MIC Testing
Academic Affairs and Research
Scope of Research
NHLS Research Trust
Training
Quality Assurance
Health Technology Assessment Unit
2012-2021
2022
Proficiency Testing
Priority Programmes
CD4
HIV Genotyping
HIV Viral Load
TB GeneXpert
Early Infant Diagnosis
Supply Chain
Latest RFQs
Latest Tenders
Received Bids
Awarded Bids
Awarded RFQ’s
Bid Cancellations
Archive
Key Documents
Annual Reports
Strategic Documents
PAIA
Acts and Bills
Media
News
Alerts
Videos
Contact Us
Careers
Vacancies
Search for:
FAQs
Home
>
Priority Programmes
>
TB GeneXpert
>
FAQs
FAQs
nhlsadmin
2018-09-16T18:39:13+00:00
